Cargando…
Lacripep for the Treatment of Primary Sjögren–Associated Ocular Surface Disease: Results of the First-In-Human Study
The purpose of this study was to assess the safety, tolerability, dosing, and efficacy of the active 19 amino acid fragment of lacritin (Lacripep), a broad regulator of ocular surface homeostasis, in the treatment of ocular surface disease associated with primary Sjögren syndrome. METHODS: Two hundr...
Autores principales: | Tauber, Joseph, Laurie, Gordon W., Parsons, Edward C., Odrich, Marc G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cornea
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895125/ https://www.ncbi.nlm.nih.gov/pubmed/35942530 http://dx.doi.org/10.1097/ICO.0000000000003091 |
Ejemplares similares
-
Bacterial distribution on the ocular surface of patients with primary Sjögren’s syndrome
por: Kim, Yong Chan, et al.
Publicado: (2022) -
Factors associated with ocular surface epithelial damage in patients with primary Sjögren’s syndrome
por: Kim, Ji Eun, et al.
Publicado: (2021) -
A systematic review of non-pharmacological interventions for primary Sjögren’s syndrome
por: Hackett, Katie L., et al.
Publicado: (2015) -
Genetic and clinical basis for two distinct subtypes of primary Sjögren’s syndrome
por: Thorlacius, Guðný Ella, et al.
Publicado: (2020) -
Mouse Models of Sjögren’s Syndrome with Ocular Surface Disease
por: Masli, Sharmila, et al.
Publicado: (2020)